Fig. 2From: Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trialFlow of participants in a study of the inactivated SARS-CoV-2 vaccine in high-risk occupational population. *Lost to follow up including not being at the study site, or illnessBack to article page